News
We are working at the cutting edge of healthcare analytics. Stay informed here.
AccurKardia Announces Clinical Pilot Study of Its AK+ Guard ECG-based, AI-powered Hyperkalemia Detection Software
NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a ...
September 2025
AccurKardia’s Finds Predictive Insights in Ubiquitous ECG
AccurKardia is using AI to mine the information contained in widely available 12-lead ECG data. The statup's mission is to ...
May 2025
AccurKardia’s AccurECG Named “Best New Technology Solution for ECG” in 9th Annual MedTech Breakthrough Awards Program
AccurKardia, an innovator in ECG-based diagnostics technology, today announced that its AccurECGTM software platform has ...
May 2025
HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation
HeartBeam Inc., a medical technology company focused on transforming cardiac care by providing powerful personalized insights, ...
April 2025
Dr. Wei Ling Lau of the UC Irvine School of Medicine Speaks to the Nephrology Times About the Promise of AK+ Guard™ for Monitoring Hyperkalemia in CKD and HF Patients
AK+ Guard is artificial intelligence–powered software that uses lead I ECG data to alert patients and clinicians of moderate to ...
January 2025
AccurKardia Receives FDA Breakthrough Device Designation for AI-powered Hyperkalemia Detection Solution Using Lead I ECG Data
AccurKardia's AK+ Guard is designed to work with a wide range of FDA-cleared consumer and clinical wearables that currently ...
January 2025
AccurKardia Receives FDA Breakthrough Device Designation for First-of-its-Kind Aortic Valve Stenosis ECG-based AI Screening Software
AccurKardia has received FDA Breakthrough Device Designation for its AI-driven ECG-based Aortic Valve Stenosis screening ...
October 2024
Selected startups will advance technology-driven improvements in heart and brain health
The American Heart Association, through its Center for Health Technology and Innovation (the Center), has selected five companies ...
June 2024
AccurKardia has been selected for the prestigious MedTech Innovator 2024 Cohort and the Heart and Brain Health Accelerator track in collaboration with the American Heart Association’s Center for Health Technology and Innovation
This year, approximately 1,300 companies applied to Medtech Innovator, and only 65 were selected (just 5%), including just ...
May 2024
AccurKardia’s AccurECG™ Analysis System Receives FDA 510(k) Clearance
AccurKardia announced today that its flagship product, the AccurECG™ Analysis System (“AccurECG” or the “System”), has been ...
July 2023
AccurKardia Announces Final Closing of $2.7 Million Series Seed Round
AccurKardia announced our final closing and completion of our $2.7 million Series Seed round. This funding milestone marks a ...
June 2023
AccurKardia's ‘AccurBeat' Found to be Promising Alternative in QT/QTc Remote Monitoring According to Study by HITLAB and SUNY Downstate
AccurKardia’s AccurBeat has been found to be a promising new alternative for QT/QTc remote monitoring according to a new study ...
October 2022
AccurKardia joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
The AccurKardia team is excited to join the Innovators’ Network. We are eager to engage with the other network members ...
August 2022
Telehealth 2.0: Remote Patient Monitoring Tools to Give Shot in the Arm to Telehealth
Our Co-Founder and CEO, Juan C. Jimenez recently authored an article published by Nasdaq on Telehealth 2.0, ...
April 2022
Health Tech: Juan Jimenez On How AccurKardia’s Technology Can Make An Important Impact On Our Overall Wellness
In this interview AccurKardia's CEO describes how the Company is improving patients' outcomes and saving lives. ...
March 2022
"AccurKardia Announces Collaboration with MDF Instruments to Develop ECG Solutions for the Next Generation of Stethoscopes"
AccurKardia today announced a collaboration with MDF Instruments to develop ECG (electrocardiogram)’ ...
January 2022
"BestStartup.us" recognizes AccurKardia in its top picks for the best New York City based Health Diagnostics companies
This article showcases 62 top picks for the best New York City based Health Diagnostics companies. AccurKardia was identified as ...
August 2021
"Life Science Intelligence" includes AccurKardia in LSI's Medtech Startup Tracker
Life Science Intelligence's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the ...
July 2021
Featured on "The Startup Pill's" 101 top picks for the best Health Diagnostics startups in 2021
This article showcases The Startup Pill’s top picks for the best Health Diagnostics startups. Accurkardia was included as one of ...
January 2021